{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:23:29Z","timestamp":1790792609380,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T00:00:00Z","timestamp":1642809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008361","name":"Scleroseforeningen","doi-asserted-by":"publisher","award":["A-34757"],"award-info":[{"award-number":["A-34757"]}],"id":[{"id":"10.13039\/100008361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.msard.2022.103529","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T11:31:42Z","timestamp":1642851102000},"page":"103529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population"],"prefix":"10.1016","volume":"59","author":[{"given":"Johanna Balslev","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malthe Faurschou","family":"Wandall-Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Magyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10130","key":"10.1016\/j.msard.2022.103529_bib0001","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.msard.2022.103529_bib0002","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1212\/WNL.0000000000005612","article-title":"Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women","volume":"90","author":"Koch-Henriksen","year":"2018","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.msard.2022.103529_bib0003","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1080\/14656566.2020.1774554","article-title":"Pharmacotherapeutic considerations in women with multiple sclerosis","volume":"21","author":"Andersen","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.msard.2022.103529_bib0004","series-title":"Aubagio","year":"2012"},{"key":"10.1016\/j.msard.2022.103529_bib0005","series-title":"Find Medicine-Aubagio","year":"2018"},{"key":"10.1016\/j.msard.2022.103529_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102521","article-title":"An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014 to 2017","volume":"46","author":"Vermersch","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103529_bib0007","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.msard.2022.103529_bib0008","first-page":"1","article-title":"The Danish multiple sclerosis registry","author":"Magyari","year":"2020","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.msard.2022.103529_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish medical birth register","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.msard.2022.103529_bib0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish national patient registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.msard.2022.103529_bib0011","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1403494811399957","article-title":"Danish registers on aspects of reproduction","volume":"39","author":"T\u00f8lb\u00f8ll Blenstrup","year":"2011","journal-title":"Scand. J. Public Health"},{"issue":"4","key":"10.1016\/j.msard.2022.103529_bib0012","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/humrep\/deaa326","article-title":"Chance of live birth: a nationwide, registry-based cohort study","volume":"36","author":"Kolte","year":"2021","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.msard.2022.103529_bib0013","doi-asserted-by":"crossref","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","author":"Schmidt","year":"2014","journal-title":"Eur. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.msard.2022.103529_bib0014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1542\/peds.98.1.141","article-title":"Use and abuse of the Apgar score","volume":"98","year":"1996","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.msard.2022.103529_bib0015","first-page":"35","article-title":"Prematurity: present and future","volume":"67","author":"Tsimis","year":"2015","journal-title":"Minerva Ginecol."},{"issue":"5\u20136","key":"10.1016\/j.msard.2022.103529_bib0016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3109\/07853890.2013.803739","article-title":"New population-based references for birth weight, length, and head circumference in singletons and twins from 23 to 43 gestation weeks","volume":"45","author":"Sankilampi","year":"2013","journal-title":"Ann. Med."},{"key":"10.1016\/j.msard.2022.103529_bib0017","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2147\/CLEP.S278596","article-title":"Congenital malformations in Denmark: considerations for the use of Danish health care registries","volume":"12","author":"Broe","year":"2020","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.msard.2022.103529_bib0018","unstructured":"FDA. Arava. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/020905s027lbl.pdf. Accessed November 11, 2021."},{"key":"10.1016\/j.msard.2022.103529_bib0019","unstructured":"EMA. Arava. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/arava. Accessed November 11, 2021."},{"key":"10.1016\/j.msard.2022.103529_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.reprotox.2020.04.073","article-title":"Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide","volume":"95","author":"Henson","year":"2020","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.msard.2022.103529_bib0021","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/annrheumdis-2017-212078","article-title":"Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes","volume":"77","author":"B\u00e9rard","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.msard.2022.103529_bib0022","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.27358","article-title":"Birth outcomes in women who have taken leflunomide during pregnancy","volume":"62","author":"Chambers","year":"2010","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.msard.2022.103529_bib0023","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1352458519843055","article-title":"Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: clinical study data and 5 years of post-marketing experience","volume":"26","author":"Vukusic","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103529_bib0024","first-page":"438","article-title":"Pregnancy outcomes for female patients and partners of male patients in the teriflunomide clinical development program","volume":"20","author":"Kieseier","year":"2014","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2022.103529_bib0026","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/CPJ.0000000000000717","article-title":"Teriflunomide-exposed pregnancies in a French cohort of patients with multiple sclerosis","volume":"10","author":"Barataud-Reilhac","year":"2020","journal-title":"Neurol. Clin. Pract."},{"issue":"28","key":"10.1016\/j.msard.2022.103529_bib0027","doi-asserted-by":"crossref","first-page":"e21212","DOI":"10.1097\/MD.0000000000021212","article-title":"Twin pregnancy outcome following teriflunomide treatment in a relapsing-remitting multiple sclerosis patient","volume":"99","author":"D'Aleo","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.msard.2022.103529_bib0028","unstructured":"Rog, D., Lebrun-Fr\u00e9nay, C., Seferta, N., Benamor, M., Truffinet, P., Ghezzi A. Teriflunomide (Aubagio\u00ae) international pregnancy registry: enrolment update. https:\/\/mstrust.org.uk\/sites\/default\/files\/Rog, D_37.pdf. Accessed October 10, 2021."},{"key":"10.1016\/j.msard.2022.103529_bib0029","unstructured":"OTIS (Organization of Teratology Information Specialists). Identifier: NCT03198351, an observational study on teriflunomide-exposed pregnancies. ClinicalTrials.gov [Internet], 2022 Bethesda (MD): National Library of Medicine (US)."},{"key":"10.1016\/j.msard.2022.103529_bib0030","unstructured":"Vukusic, S., Hellwig, K., Truffinet, P., Benamor, M., Strattman, S., Afsar, S., Purvis, A., Poole, E.M., Coyle P. Pregnancy outcomes in female partners of male patients treated with teriflunomide or leflunomide (an in vivo precursor of teriflunomide). P1146. https:\/\/onlinelibrary.ectrims-congress.eu\/ectrims\/2019\/stockholm\/278348\/sandra.vukusic.pregnancy.outcomes.in.female.partners.of.male.patients.treated.html. Accessed October 31, 2021."},{"key":"10.1016\/j.msard.2022.103529_bib0031","series-title":"Proceedings of the 29th Congress of the European Commitee for Treatment and Research in Multiple Sclerosis","article-title":"Teriflunomide mechanism of action: Linking species\u2019 sensitivities to pregnancy outcomes","author":"Davenport","year":"2013"},{"issue":"NOV","key":"10.1016\/j.msard.2022.103529_bib0032","article-title":"Pregnancy outcomes in men and women treated with teriflunomide. A population-based nationwide Danish register study","volume":"9","author":"Andersen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2022.103529_bib0033","unstructured":"Lidegaard \u00d8. Conceptions in Denmark 1998-2011; 2012. http:\/\/www.tigrab.dk\/Conceptions11\/Conceptions98-11.htm."},{"key":"10.1016\/j.msard.2022.103529_bib0034","unstructured":"\u00d6ztoprak E., Andersson C.B., Flems C. Dansk kvalitetsdatabase for f\u00f8dsler - \u00e5rsrapport 2018; 2019. https:\/\/www.sundhed.dk\/content\/cms\/67\/4667_tigrab-aarsrapport-2018.pdf."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482200044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482200044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:58:18Z","timestamp":1761901098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482200044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":33,"alternative-id":["S221103482200044X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103529","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103529"}}